Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and heparitin sulfate

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with heparitin sulfate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahsan, F; Alobaida, A; Keshavarz, A; McMurtry, IF; Nozik-Grayck, E; Stenmark, KR	1

Other Studies

1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and heparitin sulfate

Article	Year
CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil. Molecular pharmaceutics, 2019, 08-05, Volume: 16, Issue:8 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Disease Models, Animal; Half-Life; Heparitin Sulfate; Humans; Hypertension, Pulmonary; Liposomes; Lung; Male; Myocytes, Smooth Muscle; Peptides, Cyclic; Pulmonary Artery; Rats; Time Factors; Vasodilation; Vasodilator Agents	2019

Article

Year

CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil.

Molecular pharmaceutics, 2019, 08-05, Volume: 16, Issue:8

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Disease Models, Animal; Half-Life; Heparitin Sulfate; Humans; Hypertension, Pulmonary; Liposomes; Lung; Male; Myocytes, Smooth Muscle; Peptides, Cyclic; Pulmonary Artery; Rats; Time Factors; Vasodilation; Vasodilator Agents

2019